嗜睡症
医学
警觉
白天过度嗜睡
重症监护医学
临床研究
多学科方法
专家意见
临床试验
协商一致会议
替代医学
睡眠呼吸暂停
阻塞性睡眠呼吸暂停
梅德林
文档
猝倒
精神科
中枢性睡眠呼吸暂停
不利影响
系统回顾
安眠药
睡眠障碍
睡眠(系统调用)
临床疗效
同情性使用
出处
期刊:PubMed
[National Institutes of Health]
日期:2026-02-01
卷期号:65 (2): 121-141
标识
DOI:10.3760/cma.j.cn112138-20250821-00497
摘要
Wake-promoting agents mainly excite the cerebral cortex and promote wakefulness. They are clinically used to treat excessive daytime sleepiness (EDS) caused by narcolepsy and other diseases, or to maintain alertness during special tasks. In recent years, a variety of wake-promoting agents have been approved for the treatment of EDS related to narcolepsy, obstructive sleep apnea and other diseases at home and abroad. However, a dedicated expert consensus on the clinical application of wake-promoting agents remains lacking. To facilitate the rational and standardized clinical application of wake-promoting agents in China, the Sleep Disorders Committee of the Chinese Sleep Research Society convened a multidisciplinary panel of domestic experts. This assembly developed this consensus based on the latest clinical evidence sourced from both domestic and international research, as well as relevant guidelines and their collective clinical expertise. The consensus comprehensively reviews the mechanisms of action, approved indications, clinical studies, dosages, and adverse reactions of various wake-promoting agents. It also provides recommendations on drug selection, titration, and the use of wake-promoting agents in special populations for excessive daytime sleepiness caused by various etiologies. It has strong clinical guidance and clinical application value.
科研通智能强力驱动
Strongly Powered by AbleSci AI